Despite Patent Attack, Schering Will Bring Yaz To U.S.
Warner Chilcott announced on Monday that it had filed the suit in U.S. District Court for the District of New Jersey.
The U.K.-based company is accusing the German drugmaker of infringing a patent on its recently-approved Loestrin 24 Fe contraceptive by selling the oral contraceptive Yaz.
The patent at...
To view the full article, register now.